An intensive training schedule is linked to a heightened risk of non-allergic asthma in competitive cross-country skiers, finds research published in the open access journal BMJ […]
The Food and Drug Administration on Monday approved a drug called baricitinib as the first oral tablet for treating severe alopecia areata, an autoimmune disorder affecting […]
Researchers in UC Santa Barbara neuroscientist Kenneth S. Kosik’s lab have discovered a novel organelle—a previously unknown cell structure whose function it is to help clean […]
Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir, together marketed as Paxlovid. […]